Use of everolimus reduces late-onset cytomegalovirus primary disease occuring after antiviral prophylaxis discontinuation in kidney transplant recipients

Devresse, A., Avettand-Fenoel, V., Scemla, A., Morin, L., Lebreton, X., Tinel, C., Amrouche, L., Lamhaut, L., Timsit, M.-O., Zuber, J., Legendre, C., & Anglicheau D. (2017). Use of everolimus reduces late-onset cytomegalovirus primary disease occuring after antiviral prophylaxis discontinuation in kidney transplant recipients. American Journal of Transplantation. Supplement, 17(suppl 3), 232. https://hdl.handle.net/2078.5/243855 (Original work published 2017)